183 related articles for article (PubMed ID: 12622622)
1. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
Stölzel U; Köstler E; Schuppan D; Richter M; Wollina U; Doss MO; Wittekind C; Tannapfel A
Arch Dermatol; 2003 Mar; 139(3):309-13. PubMed ID: 12622622
[TBL] [Abstract][Full Text] [Related]
2. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
3. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
Tannapfel A; Stölzel U; Köstler E; Melz S; Richter M; Keim V; Schuppan D; Wittekind C
Virchows Arch; 2001 Jul; 439(1):1-5. PubMed ID: 11499833
[TBL] [Abstract][Full Text] [Related]
4. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
[TBL] [Abstract][Full Text] [Related]
5. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
6. Significance of H63D homozygosity in a Basque population with hemochromatosis.
Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
[TBL] [Abstract][Full Text] [Related]
7. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
[TBL] [Abstract][Full Text] [Related]
9. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
[TBL] [Abstract][Full Text] [Related]
10. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
[TBL] [Abstract][Full Text] [Related]
11. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.
Bulaj ZJ; Phillips JD; Ajioka RS; Franklin MR; Griffen LM; Guinee DJ; Edwards CQ; Kushner JP
Blood; 2000 Mar; 95(5):1565-71. PubMed ID: 10688809
[TBL] [Abstract][Full Text] [Related]
13. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
16. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
[TBL] [Abstract][Full Text] [Related]
17. [Porphyria cutanea tarda with sclerodermatous changes and hemochromatosis].
Wallaeys E; Thierling U; Lang E; Neumann NJ; Frank J
Hautarzt; 2014 Apr; 65(4):272-4. PubMed ID: 24718503
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
20. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
Wolff CF; Armas RM; Frank J; Poblete PG
Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]